Amgen Inc.
Chimeric receptors and methods of use thereof

Last updated:

Abstract:

Antigen binding molecules, chimeric receptors, and engineered immune cells are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.

Status:
Grant
Type:

Utility

Filling date:

31 Mar 2017

Issue date:

24 Mar 2020